Literature DB >> 16102433

Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality.

Patricia P Chang1, J Craig Longenecker, Nae-Yuh Wang, Kenneth L Baughman, John V Conte, Joshua M Hare, Edward K Kasper.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) is common in severe heart failure, but the effect of mild PH on posttransplantation PH and survival after heart transplantation has not been well described.
METHODS: This cohort study examined preoperative and postoperative hemodynamics in 172 heart transplant recipients at Johns Hopkins Hospital followed for up to 15.1 years. PH was defined as pulmonary vascular resistance > or =2.5 Wood units, as measured during routine right heat catheterization; mild to moderate PH was defined as PVR between 2.5 and 4.9 Wood units; and severe PH was defined as PVR > or =5.0 Wood units.
RESULTS: Seventy-one patients (41.3%) had PH, mostly of mild/moderate severity (77.5%), at the last routine hemodynamic monitoring before transplantation (median time before transplantation, 2.7 months). During follow-up, 105 patients (62.9%) developed PH at some point after transplantation, and 48 patients died (cumulative incidence, 76.5%). Mild/moderate preoperative PH was associated with increased risk of posttransplantation PH at 1, 3, and 6 months, but not with later episodes of PH. Mild/moderate preoperative PH was not associated with a higher mortality rate, but each 1 Wood unit increase in preoperative PVR demonstrated a trend toward increased mortality. Severe preoperative PH was associated with death within the first year after adjusting for potential confounders, but not with overall mortality or mortality at other time points.
CONCLUSIONS: Mild to moderate preoperative PH is associated with increased risk of developing early but not late posttransplantation PH and may suggest different management strategies. Although PH was not consistently associated with mortality, increasing severity of the preoperative PH suggests potentially worse prognosis.

Entities:  

Mesh:

Year:  2005        PMID: 16102433     DOI: 10.1016/j.healun.2004.07.013

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  16 in total

Review 1.  Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient.

Authors:  Christopher W Jensen; Andrew B Goldstone; Y Joseph Woo
Journal:  Curr Heart Fail Rep       Date:  2016-06

2.  Right Ventricular Dysfunction and Its Contribution to Morbidity and Mortality in Left Ventricular Heart Failure.

Authors:  Amresh Raina; Talha Meeran
Journal:  Curr Heart Fail Rep       Date:  2018-04

3.  Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Masaru Hatano; Naoko Kato; Shun Minatsuki; Hironori Muraoka; Toshiro Inaba; Hisataka Maki; Taro Shiga; Atsushi Yao; Shunei Kyo; Minoru Ono; Ryozo Nagai
Journal:  J Artif Organs       Date:  2012-09-27       Impact factor: 1.731

4.  Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation.

Authors:  Babak Daftari; Juan Carlos Alejos; Gregory Perens
Journal:  J Transplant       Date:  2010-03-10

5.  Effect of bosentan on pulmonary hypertension secondary to systolic heart failure.

Authors:  Margherita Padeletti; Maria Caputo; Valerio Zacà; Charilos Tsioulpas; Sonia Bernazzali; Sergio Mondillo; Massimo Maccherini; Sanja Jelic
Journal:  Pharmacology       Date:  2013-11-29       Impact factor: 2.547

Review 6.  Evaluation of a Heart Transplant Candidate.

Authors:  Sook Jin Lee; Kyung Hee Kim; Suk Keun Hong; Shelley Hankins
Journal:  Curr Cardiol Rep       Date:  2017-11-04       Impact factor: 2.931

7.  Changes in echocardiographic parameters of the donor's heart before and after heart transplantation and their relationship with post-transplant survival.

Authors:  Shaoxin Zheng; Ling Li; Liu Liu; Shi Liang; Jun Tao; Jingfeng Wang; Junmeng Zheng
Journal:  Ann Transl Med       Date:  2022-03

8.  Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension.

Authors:  Ana García-Álvarez; Daniel Pereda; Inés García-Lunar; David Sanz-Rosa; Rodrigo Fernández-Jiménez; Jaime García-Prieto; Mario Nuño-Ayala; Federico Sierra; Evelyn Santiago; Elena Sandoval; Paula Campelos; Jaume Agüero; Gonzalo Pizarro; Víctor I Peinado; Leticia Fernández-Friera; José M García-Ruiz; Joan A Barberá; Manuel Castellá; Manel Sabaté; Valentín Fuster; Borja Ibañez
Journal:  Basic Res Cardiol       Date:  2016-06-21       Impact factor: 17.165

9.  Hemodynamic Characteristics Including Pulmonary Hypertension at Rest and During Exercise Before and After Heart Transplantation.

Authors:  Jakob Lundgren; Göran Rådegran
Journal:  J Am Heart Assoc       Date:  2015-07-21       Impact factor: 5.501

Review 10.  Estimating Right Atrial Pressure Using Ultrasounds: An Old Issue Revisited With New Methods.

Authors:  Renato De Vecchis; Cesare Baldi; Giuseppe Giandomenico; Marco Di Maio; Anna Giasi; Carmela Cioppa
Journal:  J Clin Med Res       Date:  2016-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.